<p>A) Refractoriness pre (black bars) and post (white bars) single oxaliplatin infusion demonstrating significant change post-oxaliplatin in motor axons (Refractoriness Pre: 31.7±6.4%; Post 68.8±14.5%; <i>P</i>≤.001). B) Strength-duration time constant pre (black bars) and post (white bars) oxaliplatin infusion, demonstrating unchanged results following oxaliplatin treatment (Pre: 0.395±0.01 ms; Post: 0.394±0.02 ms; NS). C) Inset diagram of the changes in the recovery cycle of excitability pre- (black circles) and post-oxaliplatin infusion (white circles) for all patients, with error bars representing standard error of the mean and refractoriness outlined by a box and an arrow demonstrating direction of change.</p
<p>This top graph illustrates time-fluorescent uptake curves as percent change from baseline (t = 0 ...
Purpose: Oxaliplatin is a novel platinum compound with clinical activity in several malignancies. Ne...
Neurotoxic effects of oxaliplatin chemotherapy, including proprioceptive impairments, are debilitati...
<p>A) Refractoriness pre (black bars) and post (white bars) oxaliplatin treatment (Pre: 31.4±5.4%; P...
<p>A) Relationship of Na<sup>+</sup> channel-associated parameters with single oxaliplatin dose leve...
<p>A) Correlation of cumulative oxaliplatin dose with refractoriness pre-oxaliplatin infusion in sen...
BACKGROUND: Oxaliplatin, a platinum-based chemotherapy utilised in the treatment of colorectal cance...
OBJECTIVE: Neurotoxicity is the most frequent dose-limiting side effect of the anti-cancer agent oxa...
This thesis examines the pathophysiology underlying chemotherapy-induced neurotoxicity. Oxaliplatin,...
Oxaliplatin, an effective cytotoxic treatment in combination with 5-fluorouracil for colorectal canc...
<p>Oxaliplatin (4 mg/kg) was administered i.v. twice per week for 4 weeks (days 1, 2, 8, 9, 15, 16, ...
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropath
[[abstract]]Oxaliplatin (OXAL) is a platinum-based chemotherapeutic agent which is effective against...
AbstractOne form of neurotoxicity is the principal and dose-limiting toxicity of oxaliplatin. It has...
Persistent neurotoxic side effects of oxaliplatin (OX) chemotherapy, including sensory ataxia, limit...
<p>This top graph illustrates time-fluorescent uptake curves as percent change from baseline (t = 0 ...
Purpose: Oxaliplatin is a novel platinum compound with clinical activity in several malignancies. Ne...
Neurotoxic effects of oxaliplatin chemotherapy, including proprioceptive impairments, are debilitati...
<p>A) Refractoriness pre (black bars) and post (white bars) oxaliplatin treatment (Pre: 31.4±5.4%; P...
<p>A) Relationship of Na<sup>+</sup> channel-associated parameters with single oxaliplatin dose leve...
<p>A) Correlation of cumulative oxaliplatin dose with refractoriness pre-oxaliplatin infusion in sen...
BACKGROUND: Oxaliplatin, a platinum-based chemotherapy utilised in the treatment of colorectal cance...
OBJECTIVE: Neurotoxicity is the most frequent dose-limiting side effect of the anti-cancer agent oxa...
This thesis examines the pathophysiology underlying chemotherapy-induced neurotoxicity. Oxaliplatin,...
Oxaliplatin, an effective cytotoxic treatment in combination with 5-fluorouracil for colorectal canc...
<p>Oxaliplatin (4 mg/kg) was administered i.v. twice per week for 4 weeks (days 1, 2, 8, 9, 15, 16, ...
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropath
[[abstract]]Oxaliplatin (OXAL) is a platinum-based chemotherapeutic agent which is effective against...
AbstractOne form of neurotoxicity is the principal and dose-limiting toxicity of oxaliplatin. It has...
Persistent neurotoxic side effects of oxaliplatin (OX) chemotherapy, including sensory ataxia, limit...
<p>This top graph illustrates time-fluorescent uptake curves as percent change from baseline (t = 0 ...
Purpose: Oxaliplatin is a novel platinum compound with clinical activity in several malignancies. Ne...
Neurotoxic effects of oxaliplatin chemotherapy, including proprioceptive impairments, are debilitati...